The early assessment of new symptomatic drugs for Alzheimer disease remains difficult because of the lack of predictive end-point. The use of a battery including different parameters could improve this early development. In healthy volunteers, to test the reverse effect of symptomatic drugs, it is necessary to induce transient and reversible cognitive impairment and cerebral activity changes by a challenge test. In this context, a transient hypoxia could be relevant.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
OTHER
Masking
NONE
Enrollment
20
During this period, the FiO2 will be set on 21% (normoxia condition). A filter will be put between the mask and the tubes connecting it to the machine generating hypoxia (equipment reference = Altitrainer NP190). On that filter a gas analyser will monitor the FiO2 and a capnography monitor (Capnostream 20, ORIDION) will also be installed.
Centre d'Investigation Clinique, CHRU
Lille, France
NOT_YET_RECRUITINGCentre d'investigation Clinique
Marseille, France
RECRUITINGthe mean of response latency to the Rapid Visual Information Processing (RVIP) test of the CANTAB battery
Time frame: Between baseline (normoxic period) and Day 0 (hypoxia session )
The number of adverse events occuring during the period of hypoxia
Time frame: at the baseline and after the hypoxia session (day0)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.